Cart
sales@molnova.com
EMD638683
CAS No. 1181770-72-8
EMD638683( —— )
Catalog No. M20517 CAS No. 1181770-72-8
EMD638683a novel SGK inhibitor with antihypertensive potency(with an IC50 of 3 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 123 | In Stock |
|
| 2MG | 93 | In Stock |
|
| 5MG | 154 | In Stock |
|
| 10MG | 245 | In Stock |
|
| 25MG | 377 | In Stock |
|
| 50MG | 535 | In Stock |
|
| 100MG | 762 | In Stock |
|
| 200MG | 1014 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEMD638683
-
NoteResearch use only, not for human use.
-
Brief DescriptionEMD638683a novel SGK inhibitor with antihypertensive potency(with an IC50 of 3 μM).
-
DescriptionEMD638683a novel SGK inhibitor with antihypertensive potency(with an IC50 of 3 μM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorSGK1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1181770-72-8
-
Formula Weight364.34
-
Molecular FormulaC18H18F2N2O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:50 mg/mL (137.23 mM)
-
SMILESCCc1c(C)c(O)ccc1C(=O)NNC(=O)C(O)c1cc(F)cc(F)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Towhid S T Liu G L Ackermann T F et al. Inhibition of Colonic Tumor Growth by the Selective SGK Inhibitor EMD638683[J]. Cellular Physiology and Biochemistry 2013 32(4):838-848.
molnova catalog
related products
-
α-Helical CRF (9-41)
α-Helical Corticotropin Releasing Factor (9-41) is a corticotropin releasing factor (CRF) antagonist. α-Helical Corticotropin Releasing Factor (9-41) decreases plasma growth hormone (GH) values in vivo.
-
Chromium(III) acetat...
Chromium(III) acetate （Chromium acetate） is a small molecule ionic crosslinker that is used as a feedstock for the synthesis of other compounds.
-
8-Prenylkaempferol
8-Prenylkaempferol is an effective agent for attenuating pro-inflammatory NO induction, it may be an anti-inflammatory agent for suppressing influenza A virus-induced RANTES production acts by blocking PI3K-mediated transcriptional activation of NF-κB and IRF-3 and in part by interfering with IκB degradation which subsequently decreases NF-κB translocation.
